Cargando…

PB.41. What is the incidence of internal mammary node lymphadenopathy on CT in primary breast cancer patients within 1 year of a diagnosis?

Detalles Bibliográficos
Autores principales:	Savaridas, S, Cox, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243089/ http://dx.doi.org/10.1186/bcr3707

Ejemplares similares

Incidence and Potential Significance of Internal Mammary Lymphadenopathy on Computed Tomography in Patients with a Diagnosis of Primary Breast Cancer
por: Savaridas, Sarah L, et al.
Publicado: (2015)

Penicillosis with lymphadenopathy mimicing tuberculosis
por: Borthakur, Biswadeep, et al.
Publicado: (2014)

Morphological spectrum of lymphadenopathy in AIDS patients
por: Pai, Kanthilatha, et al.
Publicado: (2014)

PB.41: Audit of screening-detected breast cancers with discordant interpretations on double-read screening mammography
por: Batohi, B, et al.
Publicado: (2013)

Occult breast carcinoma presenting with axillary lymphadenopathy
por: Crotch-Harvey, MA
Publicado: (2011)

Large-bore vacuum-assisted biopsy of axillary lymphadenopathy
por: Forester, ND, et al.
Publicado: (2011)

Immune consequences of CT-guided radiation therapy of mouse mammary tumors
por: Gough, Michael J, et al.
Publicado: (2013)

PB.50: Axillary lymph node ultrasound in breast cancer patients: what minimum threshold for diffuse cortical thickening predicts nodal involvement?
por: Clarke, L, et al.
Publicado: (2013)

PB.2. Axillary node ultrasound in breast cancer: which threshold for 'diffuse cortical thickening' predicts node metastasis?
por: Hamilton, P, et al.
Publicado: (2014)

The Metastatic Rate of Internal Mammary Lymph Nodes When Metastasis of Internal Mammary Lymph Node Is Suspected on PET/CT
por: Choi, Jung Eun
Publicado: (2013)

PB.52: Incidence and clinical significance of focal breast uptake at 18-fluorine fluorodeoxyglucose PET-CT in patients without known breast cancer
por: Arce-Calisaya, P, et al.
Publicado: (2013)

PB.39. CT or not CT: a systematic review of the breast on CT of the chest and abdomen over 1 year - another screening tool?
por: Flais, S, et al.
Publicado: (2014)

Two functionally distinct epithelial progenitors exist within the luminal cell compartment of the mouse mammary gland
por: Stingl, J, et al.
Publicado: (2008)

PB.16. Breast screening mammograms: recall or not to recall. What is the golden ratio?
por: Sever, AR, et al.
Publicado: (2014)

Modelling of the impact of replacing four-node sampling with sentinel lymph node biopsy within the NHS Breast Screening Programme
por: Cheung, CS, et al.
Publicado: (2006)

Definition of Internal Mammary Node Target Volume Based on the Position of the Internal Mammary Sentinel Lymph Nodes Presented on SPECT/CT Fusion Images
por: Wang, Xue, et al.
Publicado: (2020)

PB.1. Axillary lymph node ultrasound and needle sampling in preoperative staging of breast cancer: re-audit
por: Hamilton, P, et al.
Publicado: (2014)

This abstract has also been published as O41
Publicado: (2011)

P41 - Preexposure prophylaxis of infants’ food allergy
por: Denisova, Svetlana, et al.
Publicado: (2014)

PB.4. Ultrasound false negative preoperative axillary assessment in breast cancer patients undergoing sentinel node biopsy
por: Grosvenor, L, et al.
Publicado: (2014)

PB.51: Axillary lymph node ultrasound and fine needle aspiration in preoperative staging of breast cancer: re-audit
por: Kazi, H, et al.
Publicado: (2013)

PB.12. Audit and root-cause analysis of classification 2 and 3 interval cancers
por: Cox, D, et al.
Publicado: (2014)

Incidence of adrenal insufficiency within 10 days of traumatic brain injury
por: Bernard, F, et al.
Publicado: (2005)

PB.30: What is your biopsy threshold in symptomatic clinic and what should it be? B2:B5 biopsy ratio: 18 months in our centre
por: Gray, R, et al.
Publicado: (2013)

Regulation of mammary epithelial architecture by PTEN
por: Lim, JC, et al.
Publicado: (2010)

PB.40. What happens to the ductal carcinoma in situ in HER2-positive cancers treated with neoadjuvant chemotherapy and trastuzumab?
por: Millican-Slater, R, et al.
Publicado: (2014)

PB.24: Is digital breast tomosynthesis helpful within a symptomatic one-stop breast clinic for characterisation of subtle findings?
por: Bansal, GJ, et al.
Publicado: (2013)

Assessing the protective efficacy of antibodies to the HIV gp41 region by active vaccination
por: Sharma, SK, et al.
Publicado: (2012)

PReS-FINAL-2231: A series of 41 mutations of TNFRAF1A
por: Chastang, MC, et al.
Publicado: (2013)

Evaluation of Epstein-Barr virus (EBV) and human herpes virus-8 (HHV-8) in HIV-associated persistent generalized lymphadenopathy (PGL)
por: Ayers, LW, et al.
Publicado: (2009)

Evaluation of different methods to obtain primary mammary epithelial cell cultures from canine spontaneous mammary gland tumors
por: Gentile, Luciana B, et al.
Publicado: (2013)

Mechanisms of relaxant activity of BAY 41-2272 in rat tracheal smooth muscle in vitro
por: Toque, Haroldo AF, et al.
Publicado: (2009)

P02.41. Yoga for musculoskeletal conditions: a systematic review of intervention protocols
por: Ward, L, et al.
Publicado: (2012)

Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
por: Han, D, et al.
Publicado: (2012)

Analysis of gp41 epitopes in model viral membranes to study HIV-1 neutralization
por: Reichart, T, et al.
Publicado: (2012)

41. A common rheumatology referral of vague constitutional symptoms and raised inflammatory markers
por: Brock, James
Publicado: (2019)

P-cadherin expression in feline mammary tissues
por: Figueira, A Catarina, et al.
Publicado: (2010)

Morphogenesis of the mammary gland and the role of keratin expression
por: Aldahmash, A, et al.
Publicado: (2005)

Mammary development fate and breast cancer risk
por: Medina, D
Publicado: (2005)

Contribution of genomic variations within human β-defensin 1 to incidence and outcome of severe sepsis
por: Fang, X, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_p80tp2r9p615fqlv2s0horid3f